NCT03420274View on ClinicalTrials.gov

Ensuring Patients' Informed Access to Noninvasive Prenatal Testing

NACompletedINTERVENTIONAL
Enrollment

644

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

April 30, 2022

Study Completion Date

June 15, 2023

Conditions
Genetic DiseaseGenetic SyndromePrenatal DisorderPrenatal Maternal AbnormalityPregnancy Complications
Interventions
BEHAVIORAL

NEST

This is a point-of-care shared decision-making instrument.

BEHAVIORAL

Usual care

This group will utilize usual care with respect to healthcare provider practice for education and counseling.

Trial Locations (2)

44109

MetroHealth Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

Indiana University

OTHER

collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

The Cleveland Clinic

OTHER

NCT03420274 - Ensuring Patients' Informed Access to Noninvasive Prenatal Testing | Biotech Hunter | Biotech Hunter